TreeWAS – Variant ID: rs12576775

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I20.0 Unstable angina	0.000	0.971	0.029
G40.9 Epilepsy, unspecified	0.017	0.983	0.000
I20 Angina pectoris	0.000	0.990	0.010
F20.0 Paranoid schizophrenia	0.010	0.990	0.000
I20.8 Other forms of angina pectoris	0.000	0.991	0.009
M22.2 Patellofemoral disorders	0.009	0.991	0.000
F17.1 Harmful use	0.000	0.992	0.008
M22.4 Chondromalacia patellae	0.008	0.992	0.000
M22 Disorders of patella	0.008	0.992	0.000
M22.8 Other disorders of patella	0.008	0.992	0.000
I20.1 Angina pectoris with documented spasm	0.000	0.993	0.007
C92.1 Chronic myeloid leukaemia	0.000	0.993	0.007
F20 Schizophrenia	0.007	0.993	0.000
Z57.2 Occupational exposure to dust	0.006	0.994	0.000
M22.9 Disorder of patella, unspecified	0.006	0.994	0.000
G40 Epilepsy	0.006	0.994	0.000
M22.1 Recurrent subluxation of patella	0.006	0.994	0.000
T39.0 Salicylates	0.000	0.994	0.006
H50.1 Divergent concomitant strabismus	0.006	0.994	0.000
M22.0 Recurrent dislocation of patella	0.006	0.994	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.006	0.994	0.000
H50.2 Vertical strabismus	0.006	0.994	0.000
F20.9 Schizophrenia, unspecified	0.006	0.994	0.000
F20.5 Residual schizophrenia	0.005	0.994	0.000
H50.9 Strabismus, unspecified	0.006	0.994	0.000
H50 Other strabismus	0.006	0.994	0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.005	0.995	0.000
F20.8 Other schizophrenia	0.005	0.995	0.000
F20.6 Simple schizophrenia	0.005	0.995	0.000
F20.4 Postschizophrenic depression	0.005	0.995	0.000
F20.3 Undifferentiated schizophrenia	0.005	0.995	0.000
F20.2 Catatonic schizophrenia	0.005	0.995	0.000
F20.1 Hebephrenic schizophrenia	0.005	0.995	0.000
S05.8 Other injuries of eye and orbit	0.005	0.995	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.995	0.005
G40.7 Petit mal, unspecified, without grand mal seizures	0.005	0.995	0.000
M22.3 Other derangements of patella	0.005	0.995	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.005	0.995	0.000
M22.10 Recurrent subluxation of patella, unspecified knee	0.004	0.995	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.004	0.996	0.000
H50.6 Mechanical strabismus	0.004	0.996	0.000
H50.0 Convergent concomitant strabismus	0.004	0.996	0.000
G40.8 Other epilepsy	0.004	0.996	0.000
H50.3 Intermittent heterotropia	0.004	0.996	0.000
H50.8 Other specified strabismus	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.996	0.004
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.996	0.004
Z57 Occupational exposure to risk-factors	0.004	0.996	0.000
S05 Injury of eye and orbit	0.004	0.996	0.000
G40.5 Special epileptic syndromes	0.004	0.996	0.000
S05.9 Injury of eye and orbit, part unspecified	0.004	0.996	0.000
C44.4 Skin of scalp and neck	0.000	0.996	0.004
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
H50.5 Heterophoria	0.004	0.996	0.000
H50.4 Other and unspecified heterotropia	0.004	0.996	0.000
S05.1 Contusion of eyeball and orbital tissues	0.004	0.996	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.996	0.004
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.004	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.996	0.004
Q27.8 Other specified congenital malformations of peripheral vascular system	0.004	0.996	0.000
Q27 Other congenital malformations of peripheral vascular system	0.004	0.996	0.000
G93.2 Benign intracranial hypertension	0.000	0.996	0.004
T45.0 Antiallergic and antiemetic drugs	0.000	0.996	0.004
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
Z57.3 Occupational exposure to other air contaminants	0.003	0.996	0.000
Q27.3 Peripheral arteriovenous malformation	0.003	0.997	0.000
Q25.1 Coarctation of aorta	0.003	0.997	0.000
Q25 Congenital malformations of great arteries	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.997	0.003
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.003	0.997	0.000
M51.0 Lumbar and other intervertebral disk disorders with myelopathy	0.000	0.997	0.003
Z63.4 Disappearance and death of family member	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body	0.003	0.997	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.997	0.003
Z57.9 Occupational exposure to unspecified risk-factor	0.003	0.997	0.000
Z57.7 Occupational exposure to vibration	0.003	0.997	0.000
Z57.6 Occupational exposure to extreme temperature	0.003	0.997	0.000
Z57.4 Occupational exposure to toxic agents in agriculture	0.003	0.997	0.000
Z57.1 Occupational exposure to radiation	0.003	0.997	0.000
Z57.0 Occupational exposure to noise	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.003
T39.2 Pyrazolone derivatives	0.000	0.997	0.003
S05.7 Avulsion of eye	0.003	0.997	0.000
S05.6 Penetrating wound of eyeball without foreign body	0.003	0.997	0.000
S05.5 Penetrating wound of eyeball with foreign body	0.003	0.997	0.000
S05.4 Penetrating wound of orbit with or without foreign body	0.003	0.997	0.000
S05.3 Ocular laceration without prolapse or loss of intraocular tissue	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
Q25.6 Stenosis of pulmonary artery	0.003	0.997	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.003	0.997	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.997	0.003
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.003	0.997	0.000
Z57.8 Occupational exposure to other risk-factors	0.003	0.997	0.000
S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue	0.003	0.997	0.000
H72 Perforation of tympanic membrane	0.000	0.997	0.003
Q20-Q28 Congenital malformations of the circulatory system	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.003
G93.0 Cerebral cysts	0.000	0.997	0.003
T45.5 Anticoagulants	0.000	0.997	0.003
G93 Other disorders of brain	0.000	0.997	0.003
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.000	0.997	0.003
Q25.0 Patent ductus arteriosus	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
F22 Persistent delusional disorders	0.003	0.997	0.000
G93.3 Postviral fatigue syndrome	0.000	0.997	0.003
Q27.4 Congenital phlebectasia	0.003	0.997	0.000
Q27.2 Other congenital malformations of renal artery	0.003	0.997	0.000
Q27.1 Congenital renal artery stenosis	0.003	0.997	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.003	0.997	0.000
G93.1 Anoxic brain damage, not elsewhere classified	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.003
T45.4 Iron and its compounds	0.000	0.997	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.003
Q22 Congenital malformations of pulmonary and tricuspid valves	0.003	0.997	0.000
T50.8 Diagnostic agents	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
F22.0 Delusional disorder	0.003	0.997	0.000
N18.0 End-stage renal disease	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.997	0.003
Q22.1 Congenital pulmonary valve stenosis	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
Q25.9 Congenital malformation of great arteries, unspecified	0.003	0.997	0.000
Q25.8 Other congenital malformations of great arteries	0.003	0.997	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.003	0.997	0.000
Q25.5 Atresia of pulmonary artery	0.003	0.997	0.000
Q25.4 Other congenital malformations of aorta	0.003	0.997	0.000
Q25.3 Stenosis of aorta	0.003	0.997	0.000
Q25.2 Atresia of aorta	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
O36.8 Maternal care for other specified foetal problems	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.003
H72.2 Other marginal perforations of tympanic membrane	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
F23 Acute and transient psychotic disorders	0.003	0.997	0.000
Z56 Problems related to employment and unemployment	0.003	0.997	0.000
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.003	0.997	0.000
M43.02 Spondylolysis (Cervical region)	0.003	0.997	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.002
N18.3 Chronic kidney disease, stage 3	0.003	0.997	0.000
Z56.3 Stressful work schedule	0.003	0.997	0.000
Q24 Other congenital malformations of heart	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.002
H04.5 Stenosis and insufficiency of lachrymal passages	0.000	0.997	0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.002
T46.7 Peripheral vasodilators	0.000	0.997	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.002
Z57.5 Occupational exposure to toxic agents in other industries	0.002	0.997	0.000
F28 Other nonorganic psychotic disorders	0.002	0.997	0.000
F24 Induced delusional disorder	0.002	0.997	0.000
F21 Schizotypal disorder	0.002	0.997	0.000
H72.1 Attic perforation of tympanic membrane	0.000	0.997	0.002
Z63 Other problems related to primary support group, including family circumstances	0.002	0.997	0.000
M89.0 Algoneurodystrophy	0.002	0.998	0.000
I33.0 Acute and subacute infective endocarditis	0.000	0.998	0.002
Q26 Congenital malformations of great veins	0.002	0.998	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
F25 Schizoaffective disorders	0.002	0.998	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.002	0.998	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.002	0.998	0.000
G93.7 Reye's syndrome	0.000	0.998	0.002
K61.0 Anal abscess	0.000	0.998	0.002
Z58 Problems related to physical environment	0.002	0.998	0.000
K62.7 Radiation proctitis	0.000	0.998	0.002
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
F22.9 Persistent delusional disorder, unspecified	0.002	0.998	0.000
F22.8 Other persistent delusional disorders	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
Z56.0 Unemployment, unspecified	0.002	0.998	0.000
Q21 Congenital malformations of cardiac septa	0.002	0.998	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.002	0.998	0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.002	0.998	0.000
Q22.8 Other congenital malformations of tricuspid valve	0.002	0.998	0.000
Q22.6 Hypoplastic right heart syndrome	0.002	0.998	0.000
Q22.5 Ebstein's anomaly	0.002	0.998	0.000
Q22.4 Congenital tricuspid stenosis	0.002	0.998	0.000
Q22.3 Other congenital malformations of pulmonary valve	0.002	0.998	0.000
Q22.2 Congenital pulmonary valve insufficiency	0.002	0.998	0.000
Q22.0 Pulmonary valve atresia	0.002	0.998	0.000
Z49.0 Preparatory care for dialysis	0.002	0.998	0.000
Q24.5 Malformation of coronary vessels	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
G91.1 Obstructive hydrocephalus	0.000	0.998	0.002
Q21.0 Ventricular septal defect	0.002	0.998	0.000
T36.0 Penicillins	0.000	0.998	0.002
T42.4 Benzodiazepines	0.000	0.998	0.002
M89.03 Algoneurodystrophy (Forearm)	0.002	0.998	0.000
Q23.0 Congenital stenosis of aortic valve	0.002	0.998	0.000
C92 Myeloid leukaemia	0.000	0.998	0.002
M89.00 Algoneurodystrophy (Multiple sites)	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
G99.2 Myelopathy in diseases classified elsewhere	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
N18.8 Other chronic renal failure	0.002	0.998	0.000
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
M89.96 Disorder of bone, unspecified (Lower leg)	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
Z56.7 Other and unspecified problems related to employment	0.002	0.998	0.000
Z56.6 Other physical and mental strain related to work	0.002	0.998	0.000
Z56.5 Uncongenial work	0.002	0.998	0.000
Z56.4 Discord with boss and workmates	0.002	0.998	0.000
Z56.2 Threat of job loss	0.002	0.998	0.000
Z56.1 Change of job	0.002	0.998	0.000
Z58.1 Exposure to air pollution	0.002	0.998	0.000
Z63.5 Disruption of family by separation and divorce	0.002	0.998	0.000
Z65 Problems related to other psychosocial circumstances	0.002	0.998	0.000
Z62 Other problems related to upbringing	0.002	0.998	0.000
Z61 Problems related to negative life events in childhood	0.002	0.998	0.000
Z55 Problems related to education and literacy	0.002	0.998	0.000
F23.8 Other acute and transient psychotic disorders	0.002	0.998	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.002	0.998	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.002	0.998	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.002	0.998	0.000
G93.5 Compression of brain	0.000	0.998	0.002
F25.9 Schizoaffective disorder, unspecified	0.002	0.998	0.000
Q21.3 Tetralogy of Fallot	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
B00.1 Herpesviral vesicular dermatitis	0.000	0.998	0.002
Q24.6 Congenital heart block	0.002	0.998	0.000
Q24.4 Congenital subaortic stenosis	0.002	0.998	0.000
Q24.3 Pulmonary infundibular stenosis	0.002	0.998	0.000
Q24.2 Cor triatriatum	0.002	0.998	0.000
Q24.1 Levocardia	0.002	0.998	0.000
Q24.0 Dextrocardia	0.002	0.998	0.000
S27.0 Traumatic pneumothorax	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
M89.09 Algoneurodystrophy (Site unspecified)	0.002	0.998	0.000
M89.06 Algoneurodystrophy (Lower leg)	0.002	0.998	0.000
K90.0 Coeliac disease	0.000	0.998	0.002
M89.9 Disorder of bone, unspecified	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
Z59 Problems related to housing and economic circumstances	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T42.0 Hydantoin derivatives	0.000	0.998	0.002
G93.6 Cerebral oedema	0.000	0.998	0.002
Q28 Other congenital malformations of circulatory system	0.002	0.998	0.000
M89.04 Algoneurodystrophy (Hand)	0.002	0.998	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.002	0.998	0.000
G93.8 Other specified disorders of brain	0.000	0.998	0.002
Z63.9 Problem related to primary support group, unspecified	0.002	0.998	0.000
Z63.6 Dependent relative needing care at home	0.002	0.998	0.000
Z63.3 Absence of family member	0.002	0.998	0.000
Z63.2 Inadequate family support	0.002	0.998	0.000
Z63.1 Problems in relationship with parents and in-laws	0.002	0.998	0.000
M89.08 Algoneurodystrophy (Other)	0.002	0.998	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.002	0.998	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.002	0.998	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.002	0.998	0.000
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.002	0.998	0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
Q20.6 Isomerism of atrial appendages	0.002	0.998	0.000
Q20.5 Discordant atrioventricular connexion	0.002	0.998	0.000
Q20.4 Double inlet ventricle	0.002	0.998	0.000
Q20.3 Discordant ventriculoarterial connexion	0.002	0.998	0.000
Q20.2 Double outlet left ventricle	0.002	0.998	0.000
Q20.1 Double outlet right ventricle	0.002	0.998	0.000
Q20.0 Common arterial trunk	0.002	0.998	0.000
Q26.9 Congenital malformation of great vein, unspecified	0.002	0.998	0.000
Q26.8 Other congenital malformations of great veins	0.002	0.998	0.000
Q26.6 Portal vein-hepatic artery fistula	0.002	0.998	0.000
Q26.5 Anomalous portal venous connexion	0.002	0.998	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.002	0.998	0.000
Q26.3 Partial anomalous pulmonary venous connexion	0.002	0.998	0.000
Q26.2 Total anomalous pulmonary venous connexion	0.002	0.998	0.000
Q26.1 Persistent left superior vena cava	0.002	0.998	0.000
Q26.0 Congenital stenosis of vena cava	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.000	0.998	0.002
F25.8 Other schizoaffective disorders	0.002	0.998	0.000
F25.2 Schizoaffective disorder, mixed type	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
Z49.1 Extracorporeal dialysis	0.002	0.998	0.000
F25.0 Schizoaffective disorder, manic type	0.002	0.998	0.000
G93.4 Encephalopathy, unspecified	0.000	0.998	0.002
M43.0 Spondylolysis	0.002	0.998	0.000
Z58.5 Exposure to other pollution	0.002	0.998	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.002	0.998	0.000
G91.2 Normal-pressure hydrocephalus	0.000	0.998	0.002
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.002	0.998	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.002	0.998	0.000
Q23.4 Hypoplastic left heart syndrome	0.002	0.998	0.000
Q23.3 Congenital mitral insufficiency	0.002	0.998	0.000
Q23.2 Congenital mitral stenosis	0.002	0.998	0.000
Z58.9 Problem related to physical environment, unspecified	0.002	0.998	0.000
Z58.7 Exposure to tobacco smoke	0.002	0.998	0.000
Z58.6 Inadequate drinking-water supply	0.002	0.998	0.000
Z58.4 Exposure to radiation	0.002	0.998	0.000
Z58.3 Exposure to soil pollution	0.002	0.998	0.000
Z58.2 Exposure to water pollution	0.002	0.998	0.000
Z58.0 Exposure to noise	0.002	0.998	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.000	0.998	0.002
M89 Other disorders of bone	0.002	0.998	0.000
I65.2 Occlusion and stenosis of carotid artery	0.000	0.998	0.002
Z64 Problems related to certain psychosocial circumstances	0.002	0.998	0.000
S42.90 Fracture of shoulder girdle, part unspecified (closed)	0.002	0.998	0.000
Q21.9 Congenital malformation of cardiac septum, unspecified	0.002	0.998	0.000
Q21.8 Other congenital malformations of cardiac septa	0.002	0.998	0.000
Q21.4 Aortopulmonary septal defect	0.002	0.998	0.000
Q21.2 Atrioventricular septal defect	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
Z58.8 Other problems related to physical environment	0.002	0.998	0.000
G91 Hydrocephalus	0.000	0.998	0.002
N18 Chronic renal failure	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.998	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.998	0.002
C92.5 Acute myelomonocytic leukaemia	0.000	0.998	0.002
C92.3 Myeloid sarcoma	0.000	0.998	0.002
C92.2 Subacute myeloid leukaemia	0.000	0.998	0.002
N90.5 Atrophy of vulva	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
G90-G99 Other disorders of the nervous system	0.000	0.998	0.002
M43.09 Spondylolysis (Site unspecified)	0.002	0.998	0.000
I99 Other and unspecified disorders of circulatory system	0.000	0.998	0.002
M89.98 Disorder of bone, unspecified (Other)	0.002	0.998	0.000
S42.20 Fracture of upper end of humerus (closed)	0.000	0.998	0.002
Z55.9 Problems relating to education and literacy, unspecified	0.002	0.998	0.000
Z55.8 Other problems relating to education and literacy	0.002	0.998	0.000
Z55.4 Educational maladjustment and discord with teachers and classmates	0.002	0.998	0.000
Z55.3 Underachievement in school	0.002	0.998	0.000
Z55.2 Failed examinations	0.002	0.998	0.000
Z55.1 Schooling unavailable and unattainable	0.002	0.998	0.000
Z55.0 Illiteracy and low-level literacy	0.002	0.998	0.000
Z59.9 Problem relating to housing and economic circumstances, unspecified	0.002	0.998	0.000
Z61.9 Negative life events in childhood, unspecified	0.002	0.998	0.000
Z61.8 Other negative life events in childhood	0.002	0.998	0.000
Z61.7 Personal frightening experience in childhood	0.002	0.998	0.000
Z61.6 Problems related to alleged physical abuse of child	0.002	0.998	0.000
Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group	0.002	0.998	0.000
Z61.4 Problems related to alleged sexual abuse of child by person within primary support group	0.002	0.998	0.000
Z61.3 Events resulting in loss of self-esteem in childhood	0.002	0.998	0.000
Z61.2 Altered pattern of family relationships in childhood	0.002	0.998	0.000
Z61.1 Removal from home in childhood	0.002	0.998	0.000
Z61.0 Loss of love relationship in childhood	0.002	0.998	0.000
Z62.9 Problem related to upbringing, unspecified	0.002	0.998	0.000
Z62.8 Other specified problems related to upbringing	0.002	0.998	0.000
Z62.6 Inappropriate parental pressure and other abnormal qualities of upbringing	0.002	0.998	0.000
Z62.5 Other problems related to neglect in upbringing	0.002	0.998	0.000
Z62.4 Emotional neglect of child	0.002	0.998	0.000
Z62.3 Hostility towards and scapegoating of child	0.002	0.998	0.000
Z62.2 Institutional upbringing	0.002	0.998	0.000
Z62.1 Parental overprotection	0.002	0.998	0.000
Z62.0 Inadequate parental supervision and control	0.002	0.998	0.000
Z65.9 Problem related to unspecified psychosocial circumstances	0.002	0.998	0.000
Z65.8 Other specified problems related to psychosocial circumstances	0.002	0.998	0.000
Z65.5 Exposure to disaster, war and other hostilities	0.002	0.998	0.000
Z65.4 Victim of crime and terrorism	0.002	0.998	0.000
Z65.3 Problems related to other legal circumstances	0.002	0.998	0.000
Z65.2 Problems related to release from prison	0.002	0.998	0.000
Z65.1 Imprisonment and other incarceration	0.002	0.998	0.000
Z65.0 Conviction in civil and criminal proceedings without imprisonment	0.002	0.998	0.000
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.000	0.998	0.002
T42.1 Iminostilbenes	0.000	0.998	0.002
F29 Unspecified nonorganic psychosis	0.002	0.998	0.000
C43.9 Malignant melanoma of skin, unspecified	0.000	0.998	0.002
F23.9 Acute and transient psychotic disorder, unspecified	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
Z60 Problems related to social environment	0.002	0.998	0.000
M89.99 Disorder of bone, unspecified (Site unspecified)	0.002	0.998	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.002	0.998	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.002	0.998	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.002	0.998	0.000
N18.5 Chronic kidney disease, stage 5	0.002	0.998	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.002
Z59.7 Insufficient social insurance and welfare support	0.002	0.998	0.000
Z59.6 Low income	0.002	0.998	0.000
Z59.5 Extreme poverty	0.002	0.998	0.000
Z59.4 Lack of adequate food	0.002	0.998	0.000
Z59.3 Problems related to living in residential institution	0.002	0.998	0.000
Z59.2 Discord with neighbours, lodgers and landlord	0.002	0.998	0.000
Z59.1 Inadequate housing	0.002	0.998	0.000
Z63.7 Other stressful life events affecting family and household	0.002	0.998	0.000
F17 Mental and behavioural disorders due to use of tobacco	0.000	0.998	0.002
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.000	0.998	0.002
M53.3 Sacrococcygeal disorders, not elsewhere classified	0.000	0.998	0.002
Q28.9 Congenital malformation of circulatory system, unspecified	0.001	0.998	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.001	0.998	0.000
Q28.3 Other malformations of cerebral vessels	0.001	0.998	0.000
Q28.1 Other malformations of precerebral vessels	0.001	0.998	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.001	0.998	0.000
G93.9 Disorder of brain, unspecified	0.000	0.998	0.002
L03.1 Cellulitis of other parts of limb	0.002	0.998	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.000	0.998	0.002
M89.8 Other specified disorders of bone	0.002	0.998	0.000
M43.06 Spondylolysis (Lumbar region)	0.002	0.998	0.000
S64.3 Injury of digital nerve of thumb	0.002	0.998	0.000
Z59.8 Other problems relating to housing and economic circumstances	0.002	0.998	0.000
M43.08 Spondylolysis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M43.07 Spondylolysis (Lumbosacral region)	0.002	0.998	0.000
M43.05 Spondylolysis (Thoracolumbar region)	0.002	0.998	0.000
M43.04 Spondylolysis (Thoracic region)	0.002	0.998	0.000
M43.03 Spondylolysis (Cervicothoracic region)	0.002	0.998	0.000
M43.01 Spondylolysis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M43.00 Spondylolysis (Multiple sites in spine)	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.998	0.002
F25.1 Schizoaffective disorder, depressive type	0.001	0.998	0.000
G91.8 Other hydrocephalus	0.000	0.998	0.002
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.000	0.998	0.002
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.000	0.998	0.002
M89.6 Osteopathy after poliomyelitis	0.002	0.998	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.002	0.998	0.000
M89.3 Hypertrophy of bone	0.002	0.998	0.000
M89.2 Other disorders of bone development and growth	0.002	0.998	0.000
M89.1 Epiphyseal arrest	0.002	0.998	0.000
N18.1 Chronic kidney disease, stage 1	0.002	0.998	0.000
Z64.4 Discord with counsellors	0.001	0.998	0.000
Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful	0.001	0.998	0.000
Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful	0.001	0.998	0.000
Z64.1 Problems related to multiparity	0.001	0.998	0.000
G96 Other disorders of central nervous system	0.000	0.998	0.002
Z49 Care involving dialysis	0.002	0.998	0.000
G91.3 Posttraumatic hydrocephalus, unspecified	0.000	0.998	0.002
G97.1 Other reaction to spinal and lumbar puncture	0.000	0.998	0.002
Q24.8 Other specified congenital malformations of heart	0.001	0.998	0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
C92.0 Acute myeloid leukaemia	0.000	0.998	0.002
Z63.8 Other specified problems related to primary support group	0.001	0.998	0.000
S52.01 Fracture of upper end of ulna (open)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations